ABSTRACT
INTRODUCTION
The initiation of DNA replication constitutes one of the major control points in cell cycle progression. The DNA replication machinery is activated when the cell has reached a critical mass and contains sufficient levels of components, such as NTPs, that are necessary for DNA synthesis. The assembly of eukaryotic trans-acting initiator elements on cis-acting origins of replication is best understood in budding yeast. The origin recognition complex (ORC), consisting of six subunits, binds to origins throughout the cell cycle. Additional factors associate with the DNA bound ORC during G1 phase to form the pre-replication complex. These factors include Cdc6, members of the minichromosome maintenance (MCM) family, and Cdc45 (reviewed in Kelly and Brown, 2000) . Once DNA has been licensed to replicate, S phase promoting factor (consisting of various regulatory kinases; e.g., Cdc7/Dbf4 and cyclin dependent kinase, Cdc28) triggers pre-replication complexes to fire. Significantly, homologues for many of these proteins have been found in multicellular eukaryotes. For example, ORC, Cdc6, MCMs, Cdc45, Cdc7, and Cdk2 proteins are required for DNA replication in Xenopus Chong et al., 1995; Coleman et al., 1996; Findeisen et al., 1999; Jares and Blow, 2000; Kubota et al., 1995; Mimura et al., 2000; Sato et al., 1997) and mammals (Jiang and Hunter, 1997; Mendez and Stillman, 2000; Natale et al., 2000; Petersen et al., 1999; Saha et al., 1998; Sato et al., 1997; Williams et al., 1997) . Thus, both the regulatory system and functional downstream components governing the initiation of DNA replication are likely conserved in all eukaryotes.
One function of Cdc6 homologues is to load the MCMs onto chromatin, a critical step in licensing the DNA for replication (Coleman et al., 1996; Donovan et al., 1997; Tada et al., 1999) .
A purine nucleotide binding site, composed of two motifs of the type identified by Walker and coworkers (Walker et al., 1982) , is found in all Cdc6 homologues. Structural analysis of a number of NTP-binding proteins containing such motifs indicate that the Walker A motif (GxxGxGKT) or P-loop contains an invariant lysine residue, which interacts directly with the γ-phosphate of ATP and is critical for ATP binding. In contrast, the acidic residues within the Walker B motif or DExD box coordinate a magnesium ion and are essential for ATP hydrolysis (Story and Steitz, 1992) . To date, some work has probed the requirement for these sequences in yeast and human Cdc6. Mutant Walker A Cdc6 is nonfunctional in yeast (DeRyckere et al., 1999; Perkins and Diffley, 1998; Wang et al., 1999; Weinreich et al., 1999) , suggesting that Cdc6 requires ATP binding to form a productive and stable interaction with ORC and MCMs at replication origins.
Microinjection of Walker A mutant human Cdc6 (HsCdc6) into HeLa cells, however, results in a dominant negative phenotype characterized by a block in replication (Herbig et al., 1999) , suggesting that the human Walker A mutant protein disrupts the ability of endogenous wild-type Cdc6 to load MCMs stably onto chromatin. In budding yeast, alanine substitution within the Walker B motif (DE223, 224AA) produces a fully functional Cdc6 protein (Weinreich et al., 1999) , while a glutamic acid to glycine change in the Walker B motif (E224G) is dominant negative, blocking cells in late G1 or early S phase (Perkins and Diffley, 1998) . In human cells, microinjecting mutant Walker B (E285Q) HsCdc6 also results in a dominant negative phenotype (Herbig et al., 1999) . Together, these findings argue that Cdc6 ATP binding and ATP hydrolysis have separable roles, but the precise details remain unclear.
The Xenopus early embryo cell cycles are characterized by rapid oscillations between S and M phases and thus impose constraints on DNA replication that differ from those characterized in yeast and mammalian tissue culture. The egg achieves these rapid cleavages, in part, by utilizing large maternally derived stores of DNA replication machinery, including a surplus of Xcdc6. For example, phosphorylation appears to control the subcellular localization of both HsCdc6 and Xcdc6 but the activities of these proteins vary dramatically. Overexpression (Jiang et al., 1999) or microinjection (Herbig et al., 2000) of unphosphorylatable HsCdc6 inhibits DNA replication. In contrast, unphosphorylatable Xcdc6 does not act as dominant negative inhibitor, but is actually fully functional (Pelizon et al., 2000) . These interesting observations suggest that Xcdc6 may be differentially regulated in the early embryo in other respects, such as the requirement of nucleotide binding/hydrolysis.
In this report, we have assessed the activity of mutant forms of Xenopus Cdc6 (Xcdc6).
We find that recombinant Xcdc6 harboring point mutations within either the Walker A or Walker B motif are unable to restore DNA replication to a Xcdc6 depleted extract. Immunoblot analyses revealed that, when added alone, the Walker A mutant bound chromatin poorly and failed to recruit MCM to the DNA. In contrast, the Walker 
MATERIALS AND METHODS
Construction of expression vectors. All Xcdc6 alterations were constructed by polymerase chain reaction (PCR). For N-terminal Xcdc6 (amino acids 1-165), the 5' primer was used previously (Coleman et al., 1996) , wherein the initiation codon was altered to an Nde I site.
The 3' primer, GGTCCGAATTCTCAGCGCTCTGGTATAGCCGTATTCAAAGC contains an additional 10 base pairs which encodes a stop codon and an EcoR I site immediately downstream of amino acid 165. For C-terminal Xcdc6 (amino acids 166-554), the 5' primer, GGTCCGAATTCCTGTTGGCTCGTGAGAGTGAG incorporates an EcoR I site immediately upstream of amino acid 166; the 3' primer, GGTCCTCTAGAAATCCCTGAATTGAGAACATTCCC incorporates an Xba I site immediately downstream of amino acid 554. We targeted this truncated protein to the nucleus by fusing the Cterminal portion with SV40 large T antigen nuclear localization signal (NLS). This NLS was made by annealing the following oligonucleotides GATCCATGGGTGCTCCTCCAAAAAAGAAGAGAAAGGTAGCTCCAG and AATTCTGGAGCTACCTTTCTCTTCTTTTTTGGAGGAGCACCCATG to produce a double stranded oligonucleotide, which contains a 5' BamH I and 3' EcoR I restriction sites. PCR reactions contained template (50 ng), primers (0.5 pmol each), Pfu DNA polymerase (Stratagene), and the manufacturer's buffer. The reactions were cycled 30 times as follows: 94 o C, 1 min; 60 o C, 3 min; and 72 o C, 5 min. The product of the PCR amplification was used directly for subcloning into TAII (Invitrogen) and the nucleotide sequence was confirmed. For expression in Sf9 insect cells, we modified the pFastBac1 (Gibco BRL) to contain a six histidine tag (His6) and an Nde I site at its N-terminal end by subcloning nim1 coding sequences (containing an N-terminal His6 tag) from pVL1393N-His6 (Coleman et al., 1993) as a BamH I-EcoR I fragment into pFastBacI to produce pFastBac1-His6. N-terminal Xcdc6 was subcloned into pFastBac1-His6 as a Nde I-EcoR I fragment. C-terminal Xcdc6 was assembled in a trimolecular ligation of BamH I-EcoR I (NLS),
EcoR I-Xba I (C-terminus), and BamH I-Xba I pFastBac1-His6 (vector). The Walker A and Walker B point mutations were made using the QuikChange site-directed mutagenesis kit (Stratagene) and the following primers: GGTGCTCCTGGTACCGGCGAAACTGCGTGC and GCACGCAGTTTCGCCGGTACCAGGAGCACC (Walker A, K202E);
GGTGTTGGATGGGATGGATCAGCTGG and CCAGCTGATCCATCCCATCCAACACC (Walker B, E277G) . We verified the correct reading frame by sequencing and subcloned Bgl IINsi I fragments encompassing these mutations into pGEX 4T3-Xcdc6 (kindly provided by P.
Jackson).
Expression and purification of recombinant Xcdc6. Recombinant baculoviruses encoding N-terminal and C-terminal Xcdc6 were isolated by standard procedures (Gibco-BRL).
Sf9 insect cell lysates containing either full length (Coleman et al., 1996) , N-terminal, or Cterminal His6-Xcdc6 were prepared (Desai et al., 1992) and the histidine-tagged proteins were purified on Ni-IDA (Sigma) as described (Kumagai and Dunphy, 1995) and washed three times each with high salt buffer (10 mM HEPES, pH 7.4, 1.5 M NaCl, 0.1% Triton-X-100, 15 mM imidazole) followed by HBS (10 mM HEPES, pH 7.4, 150 mM NaCl, 0.1 mM dithiothreitol) containing 0.2 mM phenylmethylsulfonyl fluoride (PMSF). Fractions were eluted in HBS made 500 mM in imidazole, dialyzed against HBS, drop-frozen in liquid nitrogen, and stored at -80 o C.
As the mutated forms of Xcdc6 were poorly expressed using a baculovirus system (our unpublished results), mutant and wild-type Xcdc6 were produced as GST fusion proteins in bacteria (Furstenthal et al., 2001) . GST fusion proteins were expressed in BL21-CodonPlus (Stratagene) following a protocol kindly provided by L. Furstenthal and P. Jackson (Stanford University School of Medicine). Cells were grown at 37 o C, induced with 0.3 mM IPTG for 4 hr, harvested by centrifugation, resuspended in lysis buffer (10 mM sodium phosphate, pH 7.2, 0.5 M NaCl, 1 mM EGTA, 1 mM DTT, and 0.25% Tween 20), containing 0.2 mM PMSF and 10 µg/ml each of pepstatin, chymostatin, and leupeptin, drop-frozen in liquid nitrogen, and stored at -80 o C.
To purify GST-Xcdc6, the thawed lysate was sonicated and centrifuged in a F18S rotor (Sorvall) at 12,500 rpm for 30 min. The supernatant was mixed with glutathione-Sepharose (Pharmacia) prewashed in lysis buffer, and incubated with gentle agitation at 4 o C for 1 hr to facilitate binding to the beads. The GST-fusion protein/glutathione-Sepharose bead complexes were isolated by centrifugation and transferred to a 4 ml Econocolumn (Bio-Rad). After washing with 20 column volumes of lysis buffer, GST fusion proteins were eluted from the beads in lysis buffer (pH adjusted to 8.0) containing 10 mM glutathione. The proteins were eluted in fractions of 300 µl.
The peak protein fractions were pooled, dialyzed against HBS, drop-frozen in liquid nitrogen, and stored at -70 o C. Protein concentrations were determined using the Bio-Rad protein assay kit.
Xenopus egg extracts and immunodepletions. Xenopus cytostatic factor (CSF)-arrested egg extracts were prepared from unactivated eggs as described (Murray, 1991) . Xenopus CSFarrested extracts were supplemented with cycloheximide (100 µg/ml) and CaCl 2 (0.4 mM).
Immunodepletions were performed on interphase extracts (15 min postactivation) using protein Aagarose containing either affinity purified anti-Xcdc6 or control rabbit anti-mouse IgG (Zymed)
antibodies (10 µg antibody/130 µl extract). All experiments were performed using double depleted extracts and efficient removal confirmed by immunoblot analyses (our unpublished results). For most experiments, interphase extracts were supplemented with demembranated sperm chromatin (600 nuclei/µl for replication assays, 3000 nuclei/µl for chromatin blots). Chromatin blots. Chromatin blots were performed as described for Xenopus low speed supernatants (Furstenthal et al., 2001) , substituting a Beckman Microfuge E for the Beckman 152 microfuge. In some cases, endogenous wild-type Xcdc6 from undepleted egg extracts (where it is present at approximately 80 nM (Coleman et al., 1996) ) was added to Xcdc6 depleted extracts to achieve intermediate Xcdc6 concentrations, as indicated. Immunoblotting was performed using anti-Xorc2 , anti-Xcdc6 (Coleman et al., 1996) , and anti-Xmcm3 (Hua and Newport, 1998) antibodies and developed using Renaissance chemiluminescence reagent (NEN).
Cell synchronization and microinjections. HeLa cells were grown as monolayers in DMEM supplemented with antibiotics and 10% fetal bovine serum in a humidified incubator at 37 o C and 5% CO 2 . To determine the optimal G1 phase BrdU staining schedule, we synchronized cells by mitotic shake off and examined BrdU uptake at different times following replating. G1
phase lasted 7-8 hours, S phase peaked at 9-10 hours post shake off and was complete by 12-13 hours, as indicated by the appearance of mitotic cells (our unpublished results). Mitotic shake-off cells were incubated for approximately 6 hrs to ensure secure re-attachment and then, in view of the above cell cycle timing, microinjected (>200 cells for each protein). For the G1/S phase nuclear injections, cells on coverslips were synchronized by double thymidine block composed of sequential growth in media supplemented with 2 mM thymidine (14 hr), plain media (8 hr), and media supplemented with 2 mM thymidine (14 hr). Cells were subsequently released from thymidine block in plain media and immediately microinjected. After microinjection, the media was supplemented with 10 µM bromodeoxyuridine (BrdU) and 1 µM fluorodeoxyuridine (1:1000 dilution, cell proliferation labeling reagent; Amersham). Each protein sample for microinjection contained GST at a concentration of 4 mg/ml to facilitate detection of injected cells. GST fusion proteins were injected at a concentration of approximately 0.5 mg/ml. Immediately prior to microinjection, each protein sample was filtered by microfuge centrifugation at 8000 rpm for 1-2 min at 4 o C through a 0.22 µm filter unit (Ultrafree-MC, Millipore) and cleared by microfuge centrifugation at 14,000 rpm for 5 min at 4 o C. Proteins were injected into the nuclei of cells using purchased needles (Femtotips, Eppendorf Scientific) with a microinjector (model 5242, Eppendorf Scientific) and a manipulator (model 5171, Eppendorf Scientific) mounted on an inverted microscope (Nikon TE300).
Immunofluorescence. Immunostaining was performed as described (Herbig et al., 1999) .
Briefly, cells were washed three times with PBS, fixed for 20 min (3.5% formaldehyde in PBS), permeabilized with 0.2% Triton X-100 for 20 min, and incubated with 10% FBS in PBS for 1 hr.
GST was detected by staining with a rabbit polyclonal anti-GST antibody (Santa Cruz Biotechnology) at a dilution of 1:200 in PBS supplemented with 10% FBS (F-PBS) for 2 hr, followed by staining with AlexaFluor 488 goat anti-rabbit IgG conjugate (Molecular Probes) at a dilution of 1:1000 in F-PBS for 1 hr. BrdU incorporated into DNA was detected by staining with a mouse monoclonal anti-BrdU antibody (Pharmingen) at a dilution of 1:500 in F-PBS containing 125 U/ml benzon nuclease (Novagen) for 2 hr, followed by staining with AlexaFluor 594 goat anti-mouse IgG conjugate (Molecular Probes) at a dilution of 1:500 in F-PBS. The cells were then washed two times with PBS for 5 min each, and once with PBS containing 0.25 µg/ml of Hoechst (Sigma) for 5 min. All incubations with antibody were done at room temperature. The coverslips were mounted in 90% glycerol and viewed on a Nikon Eclipse E800 equipped with a 60x
objective. All images were captured at identical magnification and exposure times using a Quantix cooled CCD camera (Photometrics) with Isee software (Inovision).
Protein binding Assays.

35
S labeled untagged wild-type Xcdc6 was translated using a TNT reticulocyte (Promega) system and incubated with GST fusion proteins immobilized on glutathione agarose in the presence of 2% nonfat dry milk and washed essentially as described (Herbig et al., 1999) without any added nucleotides. The bound proteins were eluted by boiling in 2 volumes SDS sample buffer, separated by SDS-PAGE, and detected by fluorography using enhance (NEN).
ATPase reactions. ATPase reactions were performed as previously described (Herbig et al., 1999) using 25 µM [γ- 
RESULTS
The C-terminal two-thirds of Xcdc6 is necessary and sufficient for DNA replication.
To delineate the functional domains of Xcdc6, deletion mutants were constructed that contained either the C-terminal two-thirds or the N-terminal one-third of the Xenopus protein.
The Cterminal domain shows significant homology to the AAA + family of ATPases (ATPases associated with various cellular activities) (Liu et al., 2000; Perkins and Diffley, 1998) and encompasses a characteristic purine nucleotide binding site composed of Walker A and Walker B motifs ( Figure   1A ), which regulate the conformation and activity of these proteins. In contrast, the N-terminal one-third of Xcdc6 contains a putative nuclear localization signal (NLS) and a majority of the S/P or T/P motifs, which comprise potential recognition sites for Cdks and other cell cycle regulated kinases ( Figure 1A ). These features suggest that the N-terminal domain might play a regulatory role governing the activity of a C-terminal catalytic domain.
To characterize the role of the Xcdc6 domains in DNA replication, recombinant histidinetagged (His6) fusion proteins containing full length wild-type or deletion mutants of Xcdc6 were purified from baculovirus-infected Sf9 cells ( Figure 1B ). The ability of these Xcdc6 domains to restore DNA replication in Xcdc6 immunodepleted extracts was evaluated. In the DNA replication assays presented in this study, we have used sperm chromatin as a template and examined the replication that occurred during two sequential time windows (typically 0-45 min and 45-90 min) for each condition. Depending on the quality of the extract, the majority of replication is usually complete in the first time point but examining multiple time points yields useful kinetic information. In this assay, DNA replication was severely diminished in the Xcdc6 depleted extract relative to a mock depleted extract assessed in parallel ( Figure 1C , compare lanes 1-2 with 19-20), but was fully restored by addition of recombinant full length His6-Xcdc6 protein ( Figure 1C and D, g and h). The C-terminal two-thirds of Xcdc6 was also able to restore DNA replication to approximately 20% of wild-type Xcdc6 activity (Figure 1C and D, d) . In contrast, the N-terminal one-third of Xcdc6 failed to induce any replication, even when present at concentrations four fold that of wild-type Xcdc6 ( Figure 1C and D, a-c). These findings indicate that the C-terminal domain is necessary and sufficient to act in this assay.
A somewhat larger Xenopus C-terminal domain (amino acids 126-554) has full activity (Pelizon et al., 2000) , suggesting that critical elements lie between amino acids 125-165. Indeed, by analogy with the recently solved crystal structure of an archael Cdc6 homologue (Liu et al., 2000) , it is likely that Xenopus Cdc6 residues 143-164 form an alpha-helix that stabilizes the interface of the two domains that comprise the nucleotide binding site ( Figure 1A ). Addition of a mix of both the N-and C-terminal domains utilized in this study to a Xcdc6 depleted extract did not result in an increase of DNA replication relative to that observed with the C-terminal domain alone. Further, neither of these Xcdc6 truncations interfered with the ability of an undepleted egg extract to replicate chromosomal DNA (our unpublished results). Together, these findings support the idea of a C-terminal catalytic domain, an N-terminal function that is regulatory but dispensable, and inability of either separate domain to compete effectively with the function of the wild-type protein.
Intact Walker A and Walker B motifs are required for Xcdc6 activity. Since the Cterminal two-thirds of Cdc6 is sufficient to replicate DNA, we next investigated the role of the highly conserved purine nucleotide binding site within this domain. Accordingly, we mutated the critical lysine residue within the Walker A site (K202E, hereafter referred to as Xcdc6WA) and one of the conserved acidic residues within the Walker B site (E277G, hereafter referred to as Xcdc6WB) in the context of full length Xcdc6 ( Figure 1A ).
The ATPase activity of purified wild-type and mutant GST-Xcdc6 was assessed using
P]ATP as a substrate. Like its yeast (Zwerschke et al., 1994) and human (Herbig et al., 1999) homologues, wild-type GST-Xcdc6 consistently displayed weak but detectable ATPase activity ( Figure 2A , squares). The hydrolysis rate for wild-type Xcdc6 (1 pmole of GST Xcdc6 is able to hydrolyze ~3.2 pmole ATP per minute) is nearly identical to that reported for the human GSTXcdc6 protein (Herbig et al., 1999) . In contrast, GST-Xcdc6WA (Figure 2A , circles) and GSTXcdc6WB ( Figure 2A , triangles) had reduced ATPase activity. In multiple ATPase assays, we consistently observed slightly higher hydrolysis for GST-Xcdc6WA than for GST-Xcdc6WB.
Since unfused GST protein purified in parallel had no ATPase activity (our unpublished results),
we feel this residual activity of mutant Xcdc6 is likely due to the fact that replacement of a single residue may not completely abolish hydrolysis in this in vitro assay. Even with this caveat, it is clear that mutations in either the Walker A or B motif interfere with ATP hydrolysis.
We next tested whether the replication defect in Xcdc6 depleted extracts was complemented by the addition of recombinant mutant Xcdc6 ( Figure 2B and C). In addition, since
Cdc6 is known to bind chromatin in an ORC-dependent manner and recruit MCMs to DNA, we also performed chromatin immunoblot analyses ( Figure 2D and E). As expected, in the absence of Xcdc6, little DNA replication occurs ( Figure 2B , lanes 1-2) and no Xmcm3 is loaded onto DNA ( Figure 2D , lanes 13-14). Like the wild-type His6-Xcdc6 (Figure 1 ), wild-type GST-Xcdc6 completely reconstituted DNA replication in a Xcdc6 depleted extract ( Figure 2B and C, a). As anticipated, recombinant wild-type GST-Xcdc6 binds chromatin very rapidly, stays on the chromatin throughout interphase, and loads Xmcm3 efficiently ( Figure 2D , lanes 9-12) in a manner that is indistinguishable from endogenous Xcdc6 (our unpublished results). In contrast,
GST-Xcdc6WA could not restore DNA replication to a depleted extract ( Figure 2B and C, b-d).
Consistent with this mutant's lack of function in a DNA replication assay, GST-Xcdc6WA bound chromatin poorly and loaded no MCM on the DNA ( Figure 2D , lanes 1-4). A longer exposure, however, detected GST-Xcdc6WA on chromatin ( Figure 2E , compare lanes 1-4 with lanes 5-6).
Importantly, this weak GST-Xcdc6WA signal is chromatin dependent (our unpublished results), raising the possibility of a low affinity or transient chromatin interaction. Finally, GST-Xcdc6WB exhibited approximately 4% of the activity and replicated DNA at approximately 8% of the rate (see Methods) observed for wild-type GST-Xcdc6 ( Figure 2B and C, e-g). Strikingly, GSTXcdc6WB binds chromatin well, yet loads Xmcm3 poorly ( Figure 2D , lanes 5-8). This weak but detectable Xmcm3 loading in the presence of GST-Xcdc6WB correlates well with the modest DNA replication induced by high concentrations of this mutant and likely reflects an incomplete loss of ATP hydrolysis in this single amino acid substitution. Significantly, Xorc2 binds chromatin independent of wild-type or mutant Xcdc6 ( Figure 2D ) and provides a useful control. (Perkins and Diffley, 1998) , while alanine substitution of the analogous lysine in human Cdc6 (K208A) results in a dominant negative protein (Herbig et al., 1999) . In budding yeast, alanine substitution within the Walker B motif (DE223, 224AA) is fully functional (Weinreich et al., 1999) , while a glutamic acid to glycine substitution (E224G) is dominant negative (Perkins and Diffley, 1998) . It is of interest, therefore, to characterize Cdc6 Walker mutants in a system like the Xenopus egg extract in which the amounts, combinations, and timing of mutant/wild type protein addition can be precisely controlled. DNA replication was not inhibited in extracts that contained up to five fold molar excess (versus endogenous Xcdc6) of either GST-Xcdc6WA or GST-Xcdc6WB (our unpublished results). We reasoned that the failure of these mutants in inhibiting DNA replication might be due to the much higher concentration of endogenous Xcdc6 protein present in the extracts compared to the levels present in yeast and human somatic cells.
To test this hypothesis, we depleted an egg extract of endogenous Xcdc6 and added back low concentrations of wild-type GST-Xcdc6, either alone or in combination with mutant GSTXcdc6. While the absolute value of DNA replication varied between experiments, we found that reconstituting a Xcdc6 depleted extract with either 4 nM or 8 nM wild-type GST-Xcdc6 ( Figure   3A and B, b and e, respectively) reproducibly gave intermediate values of DNA replication relative to that which occurred in the presence of physiological concentrations (80 nM) of wildtype GST-Xcdc6 ( Figure 3A and B, h). This variability in absolute amount of DNA replication between experiments is likely due to a number of factors, including quality of extract, extent of Xcdc6 immunodepletion, and activity of recombinant protein. Importantly, within any given experiment, the amount of replication was reproducible and between experiments, the trends were fully consistent. Preincubation of GST-Xcdc6WA in a Xcdc6 depleted egg extract containing chromatin blocked the ability of subsequently added wild-type GST-Xcdc6 to replicate chromatin.
Similar results were obtained at both 4 nM ( Figure 3A and B, compare b and d) and 8 nM ( Figure   3A and B, compare e and g) wild-type GST-Xcdc6. At greater than 40 nM wild-type Xcdc6, however, the inhibitory activity was not apparent ( Figure 3A and B, compare h and i), arguing that high concentrations of wild-type protein can overwhelm the dominant negative phenotype. A similar dominant negative effect was observed for GST-Xcdc6WB at 8 nM ( Figure 3C and D, compare e and g) wild-type GST-Xcdc6. We did not always observe this GST-Xcdc6WB dominant negative effect at 4 nM wild-type protein ( Figure 3C and D, compare b and d), probably due to the fact that GST-Xcdc6WB alone imparts limited DNA replication ( Figure 3C and D, a; see also Figure 2 ). Taken together, these data argue that both Walker A and Walker B mutant proteins can manifest a dominant negative phenotype provided that they are added to the extract prior to pre-replication complex formation and the concentration of wild-type Xcdc6 is below 40 mM (our unpublished results). Moreover, these dominant negative phenotypes strongly argue that the recombinant mutant proteins have retained some functional properties of wild-type Xcdc6.
As outlined in the introduction, it is possible that mutations in the Xcdc6 Walker A and
Walker B motifs may result in different phenotypes depending on whether the protein is present in an embryonic or somatic cell background. To pursue this issue, we sought to characterize the Xenopus Cdc6 mutants in an established somatic system using in vivo microinjection.
Accordingly, we microinjected purified wild type and the two mutant forms of Xcdc6 into HeLa cells and monitored DNA replication. We utilized HeLa cells for these experiments for two reasons. First, Xenopus tissue culture cells grow very slowly, making synchronization problematic. Second, the Xenopus and human Cdc6 proteins share nearly 80% identity at the amino acid level and in vitro studies indicate that Xcdc6 can function in human nuclear extracts (Stoeber et al., 1998) .
HeLa cells were microinjected with proteins during early to mid G1, before pre-replication complex formation and, therefore, prior to Cdc6 activity. We tried a variety of labeling times with BrdU, from brief pulses at various times following injection to continuous labeling (from 6-17 hours). In all cases, GST-Xcdc6WA and GST-Xcdc6WB inhibited BrdU incorporation, while GST alone or wild-type Xcdc6 had no effect (Figure 4) . We determined that 60-70% of cells microinjected with either control protein (GST or wild-type GST-Xcdc6, Figure 4A , first and second row, respectively) exhibited intense BrdU staining (BrdU +/+, Figure 4B ), while only about 40% of the cells microinjected with either GST-Xcdc6WA or GST-Xcdc6WB ( Figure 4A , third and fourth row, respectively) exhibited intense BrdU staining ( Figure 4B ). In some cases, the cells had detectable BrdU incorporation but the level of incorporation was lower ( Figure 4A , third row, asterisk). These intermediately stained (BrdU +/-) nuclei may result from either slowed progression through S phase or a delayed entry into S phase and premature arrest of progression upon fixation. Consistent with the hypothesis that GST-Xcdc6WA or GST-Xcdc6WB delay S phase, the proportion of BrdU +/-nuclei was reproducibly higher in the G1 phase cells microinjected with either mutant protein relative to those microinjected with either wild-type GST-Xcdc6 or GST alone ( Figure 4B , white stacked histograms).
To investigate the difference in response of the cells to the microinjection, we performed correlation analysis of the outcomes of G1 phase experiments. We compared the percentage of (Herbig et al., 1999) . The primary difference between our studies is that we used a heterologous system, Xenopus protein into human cells, while they used an entirely homologous system. It is likely that this heterologous system accounts for the reduced magnitude in our dominant negative effect. That is, Xcdc6 may not interact efficiently with human DNA replication machinery. Alternatively, Xcdc6
may not function optimally at 37 o C, as is known to be the case for the Xenopus wee1 kinase (Kumagai and Dunphy, 1995 ).
An important negative control was to microinject into cells synchronized at the boundary when they will have already formed the pre-replication complex and thus be refractory to the presence of mutant Cdc6. Accordingly, HeLa cells were synchronized in G1/S phase, microinjected, labeled with BrdU for 9 hours, and processed for immunofluorescence. As predicted, microinjection of any of the four proteins, including the GST-Xcdc6WA and GSTXcdc6WB, had no effect on DNA replication ( Figure 4B , right histograms). Together, these data indicate that the mutant Xcdc6 proteins inhibit DNA replication in both embryonic and somatic cells, provided they are introduced prior to pre-replication complex formation. We performed additional experiments to compare the ability of GST-Xcdc6WA and GSTXcdc6WB to stimulate the activity of low concentrations of wild-type Xcdc6. Endogenous Xcdc6 was immunodepleted from egg extracts resulting in the virtual absence of DNA replication in the presence of buffer alone ( Figure 5A, lanes 1-2) . As a positive control, the extract was reconstituted with physiological concentrations of wild-type GST-Xcdc6 ( Figure 5A, lanes 3-4) , producing a level of replication defined as 100% ( Figure 5B, bar a) . As demonstrated in Figure 3 , reconstituting a Xcdc6 depleted extract with either 4 nM or 8 nM wild-type GST-Xcdc6 yielded intermediate DNA replication (Figure 5A and B, b and e, respectively). When added together with either GST-Xcdc6WA or GST-Xcdc6WB, however, DNA replication was dramatically increased (2.5-14 fold) ( Figure 5A and B, compare b-d; e-g 
Wild-type Xcdc6 facilitates Walker A mutant Xcdc6 chromatin binding. Since GST-
Xcdc6WA binds chromatin poorly ( Figure 2D and E), we investigated whether conditions that favor synergy (presence of low concentrations of wild-type Xcdc6) might promote Walker A chromatin binding. That is, if Walker A mutant Xcdc6 stimulates low concentrations of wild-type Xcdc6 through formation of functional heteroligomers, then we would anticipate increased chromatin association of GST-Xcdc6WA under these conditions. Accordingly, we supplemented a Xcdc6 depleted extract with GST-Xcdc6WA (400 nM) and an undepleted extract (known to contain 80 nM Xcdc6, (Coleman et al., 1996) ) in order to achieve low concentrations (2-16 nM) of endogenous wild-type Xcdc6, thereby reproducing conditions known to promote synergy between mutant and wild-type Xcdc6 (Figures 3 and 5) . We then incubated these chromatin containing extracts at 23 o C for 30 min, a time during which we observe maximal Xcdc6 chromatin binding.
Finally, chromatin fractions were isolated and probed for the presence of Xcdc6. When incubated in the absence of wild-type Xcdc6, GST-Xcdc6WA fails to bind chromatin at appreciable levels ( Figure 6B, lane 2) . Strikingly, the addition of low concentrations of endogenous wild-type Xcdc6
facilitates GST-Xcdc6WA chromatin binding ( Figure 6B , lanes 3-6). At higher concentrations of wild-type Xcdc6, however, the GST-Xcdc6WA binding to chromatin is greatly reduced ( Figure   6B , lane 7 To establish further the mechanism by which the mutants collectively synergize with or inhibit the activity of wild-type Xcdc6, we performed additional GST-Xcdc6WA and wild-type
Xcdc6 mixing experiments and assessed pre-replication complex formation by probing chromatin fractions for the presence of both Xcdc6 and Xmcm3. In one experiment, we preincubated chromatin with GST-Xcdc6WA prior to adding wild-type Xcdc6 ( Figure 6C , lanes 1-6). In parallel, a complementary experiment was performed in which wild-type Xcdc6 was preincubated before GST-Xcdc6WA was added ( Figure 6C , lanes 7-12). All samples were subsequently incubated and processed for immunoblot analyses at the indicated times. Since preincubating GST-Xcdc6WA with chromatin inhibits the action of low concentrations of wild-type Xcdc6
( Figure 3B ), we reasoned that we should observe less wild-type Xcdc6 and less Xmcm3 bound to chromatin under these conditions. Strikingly, significantly less Xcdc6 (wild-type and mutant) and Xmcm3 are bound to chromatin when GST-Xcdc6WA is preincubated with chromatin compared to the amounts bound when wild-type Xcdc6 is preincubated with chromatin ( Figure 6C , compare lanes 1-6 with lanes 7-12). These experiments provide support for a mechanism whereby the mutant Xcdc6 imparts its dominant negative effect by establishing a nonproductive pre-replication complex. Moreover, in view of the increased GST-Xcdc6WA chromatin binding, preincubation of wild-type Xcdc6 with chromatin may facilitate heteroligomer formation. Taken together, our data is consistent with Cdc6 functioning as an oligomer with multiple functional domains. One activity is ATP dependent; a separate activity may be structural in nature and can be fulfilled by a catalytically-dead subunit(s).
Walker A mutant Xcdc6 stimulates the activity of Walker B mutant Xcdc6.
Collectively, the above experiments indicate that GST-Xcdc6WA binds chromatin poorly and cannot restore DNA replication to a depleted extract yet can stimulate the activity of wild-type GST-Xcdc6, possibly through heterologimer formation on chromatin. To examine further the stimulatory activity of GST-Xcdc6WA, we investigated whether GST-Xcdc6WA might stimulate the activity of GST-Xcdc6WB. As expected, following immunodepletion of Xcdc6, little DNA replication occurs ( Figure 7A , lanes 1-2), while addition of wild-type GST-Xcdc6 fully reconstituted DNA replication ( Figure 7A and B, g). As shown previously (Figures 2), GSTXcdc6WB alone restored very limited DNA replication (Figure 7A and B; a, c, e). Strikingly, the addition of 400 nM GST-Xcdc6WA, which is essentially devoid of activity in this assay ( Figure   7A and B, h; see also Figures 2 and 3), with GST-Xcdc6WB resulted in increased DNA replication relative to GST-Xcdc6WB alone (Figure 7A and B; compare a, b; c, d; e, f) . From this data, we conclude that catalytically inactive GST-Xcdc6WA can stimulate catalytically impaired GST-Xcdc6WB. The mechanism underling this GST-Xcdc6WB stimulation is likely to be the same as that for the stimulation of low concentrations of wild-type Cdc6.
DISCUSSION
The data presented here suggest that Xcdc6 possesses two distinct activities and may act as an oligomer. One essential activity appears to be ATP dependent and involves Cdc6 acting as a switch that couples key events during the initiation of DNA replication. A point mutation in the Walker A motif, which likely inhibits ATP binding, results in decreased chromatin association and inability to restore DNA replication to a Xcdc6 depleted extract. In contrast, a point mutation in the Walker B motif, which inhibits ATP hydrolysis, binds chromatin well but loads MCMs poorly and is nearly nonfunctional. We demonstrate that both GST-Xcdc6WA and GST-Xcdc6WB can function as dominant negative mutants when either microinjected into HeLa cell nuclei or incubated in Xenopus egg extracts, provided they are added prior to pre-replication complex formation. These results argue that the Xenopus Cdc6 protein can interact with human DNA replication machinery, underscoring the conserved nature of eukaryotic DNA replication machinery. A second, non-ATP dependent activity of Xcdc6 was also uncovered. We found that GST-Xcdc6WA, which is nonfunctional by itself, can stimulate the activity of both wild type and catalytically impaired GST-Xcdc6WB. We present evidence that Xcdc6 can form multimers and speculate that this stimulatory activity is imparted via heteroligomer formation on chromatin.
Cdc6 may function as a clamp loader. Clamp loaders are members of the AAA + family of ATPases that function as multimeric ATP-dependent machines to assemble their respective clamps around DNA (Lee and Bell, 2000; Mossi and Hubscher, 1998; Neuwald et al., 1999) .
Despite having limited sequence similarity, the three-dimensional structures of clamp loaders are remarkably similar among archaeal, prokaryotic, and eukaryotic organisms (Hingorani and O'Donnell, 2000; Mossi and Hubscher, 1998) . Extrapolating from several well studied examples, it is likely that all clamp loaders utilize ATP binding and hydrolysis as molecular switches to couple key events in DNA metabolism (Lee and Bell, 2000) . ATP binding appears to promote stable clamp loader DNA interactions. The exact requirement for ATP hydrolysis, however, remains unclear. Although hydrolysis is not required for subsequent clamp binding, the DNA clamp complexes formed in the absence of hydrolysis are unstable (Mossi and Hubscher, 1998 ).
The energy from ATP hydrolysis, therefore, may be used to close the clamp around DNA or dissociate the clamp loader from the clamp and DNA (Hingorani et al., 1999) .
In our in vitro hydrolysis assays, GST-Xcdc6WA reproducibly had higher activity than GST-Xcdc6WB; yet in the DNA replication assays, GST-Xcdc6WB was more active. Thus, it seems unlikely that our mutants' intrinsic level of ATPase activity accounts for their different biochemical phenotypes. Indeed, given the low ATPase activity of wild-type Xenopus (present study) and human (Herbig et al., 1999) Cdc6, one wonders about the physiological relevance of this in vitro hydrolysis assay. In vivo, Cdc6 likely functions in a large macromolecular machine which hydrolyzes ATP much faster than this in vitro assay would indicate.
The results presented here, coupled with previous work in yeast (DeRyckere et al., 1999; Perkins and Diffley, 1998; Wang et al., 1999; Weinreich et al., 1999) and human cells (Herbig et al., 1999) , suggest that Cdc6 and Cdt1 (Maiorano et al., 2000; Nishitani et al., 2000) collaborates with the origin recognition complex (ORC) to load the MCM complex onto chromatin. In view of the sequence similarity and biochemical data, it is tempting to speculate that Cdc6 may function as a clamp loader in a multi-step process resulting in MCM (a potential ring-shaped clamp) recruitment around DNA. In the first step, ORC binds to DNA independent of Cdc6 ( Figure 8 , step 1). In a subsequent step, Cdc6 forms a productive interaction with ORC and DNA in a process that likely requires ATP binding ( Figure 8, step 2 ). On the basis of studies with AAA + family members, GST-Xcdc6WA is expected to have reduced ATP binding (and, therefore, hydrolysis), while GST-Xcdc6WB would maintain ATP binding but have reduced hydrolysis (Story and Steitz, 1992) . Since GST-Xcdc6WA is severely impaired with respect to chromatin binding and ability to load Xmcm3 ( Figure 2D, lanes 1-4) , the data presented herein correlate well Although it is formally possible that wild-type Xcdc6 may mediate the chromatin association of GST-Xcdc6WA in a mechanism that does not involve heteroligomer formation, we favor this oligomer model for several reasons. First, Xenopus ( Figure 6A ) and human (Herbig et al., 1999; Saha et al., 1998) Cdc6 form complexes in solution. Second, not only do low concentrations of wild-type Xcdc6 promote GST-Xcdc6WA chromatin binding ( Figure 6B ), but high concentrations of GST-Xcdc6WA also facilitate additional wild-type Xcdc6 chromatin association (our unpublished results). This mutual stimulation is suggestive of heteroligomer formation and is not an artifact of GST-mediated dimerization since we observe augmented GST-Xcdc6WA binding using untagged wild-type Xcdc6. Third, the formation of a functional Xcdc6 heteroligomer provides a mechanism to explain the observed stimulation of DNA replication under these conditions. Our bias is that oligomerization is greatly stabilized in the presence of DNA and other DNA replication components. Indeed, we present evidence that such a complex likely forms on chromatin (represented by the dimer in Figure 8 , step 2), wherein the mutant subunit(s) provide some activity (e.g., ORC/MCM binding) and the wild-type subunit(s) catalyze an essential ATP driven process (e.g., MCM loading and/or complex disassembly).
This oligomerization model is strengthened by the observation that GST-Xcdc6WA can stimulate not only wild-type Xcdc6 but also GST-Xcdc6WB (Figure 7) . In view of the recently described crystal structures of several ABC (ATP binding cassette) family members, which reveal the composite nature of ATPase active sites, the current data provide grounds for the speculation that Cdc6 may also form a dimer with a composite ATPase domain. In one example illustrating the composite nature of an ATPase active site, the two ATPase domains of the MutS mismatch repair form an interleaved ATPase interface, in which a conserved flexible loop from one monomer forms part of the opposing monomer's catalytic site (Junop et al., 2001; Lamers et al., 2000; Obmolova et al., 2000) . A composite ATPase active site may be a general feature of the ABC superfamily as a similar arrangement of two complementary ATPase domains is also observed in the DNA repair protein Rad50 (Hopfner et al., 2000) . The data present here are consistent with Cdc6 forming a dimer with a similar composite ATPase active site ( Figure 8, step 2). Although speculative, in such a composite ATPase active site, the GST-Xcdc6WB subunit might bind ATP and impart stable DNA chromatin interactions to the GST-Xcdc6WA subunit, while GST-Xcdc6WA might promote ATP hydrolysis and MCM loading.
In conclusion, the experiments presented here provide further evidence that Walker A and Background was subtracted and histograms are normalized as described in Figure 3 . 
